TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort

Autor: Molnar, Christoph, Scherer, Almut, Baraliakos, Xenofon, de Hooge, Manouk, Micheroli, Raphael, Exer, Pascale, Kissling, Rudolf O, Tamborrini, Giorgio, Wildi, Lukas M, Nissen, Michael J, Zufferey, Pascal, Bernhard, Jürg, Weber, Ulrich, Landewé, Robert B M, van der Heijde, Désirée, Ciurea, Adrian, Rheumatologists of the Swiss Clinical Quality Management Program

Publikováno v: Molnar, C, Scherer, A, Baraliakos, X, de Hooge, M, Micheroli, R, Exer, P, Kissling, R O, Tamborrini, G, Wildi, L M, Nissen, M J, Zufferey, P, Bernhard, J, Weber, U, Landewé, R B M, van der Heijde, D, Ciurea, A & Rheumatologists of the Swiss Clinical Quality Management Program 2018, ' TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity : results from the Swiss Clinical Quality Management cohort ', Annals of the Rheumatic Diseases, vol. 77, no. 1, pp. 63-69 . https://doi.org/10.1136/annrheumdis-2017-211544
Annals of the rheumatic diseases, vol. 77, no. 1, pp. 63-69
Annals of the Rheumatic Diseases, Vol. 77, No 1 (2018) pp. 63-69
Annals of the Rheumatic Diseases, 77(1), 63-69
Annals of the rheumatic diseases, 77(1), 63-69. BMJ Publishing Group

ObjectivesTo analyse the impact of tumour necrosis factor inhibitors (TNFis) on spinal radiographic progression in ankylosing spondylitis (AS).MethodsPatients with AS in the Swiss Clinical Quality Management cohort with up to 10 years of follow-up an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf092bb5e5c11fd580cecb5d08f6e4a8
https://hdl.handle.net/1887/76082